newratings.com  Mar 7  Comment 
LONDON (dpa-AFX) - ARCA biopharma Inc. (ABIO) has randomized the 175th patient in GENETIC-AF - its phase 2B/3 clinical trial evaluating Gencaro as a potential treatment for atrial fibrillation. The Data Safety Monitoring Board (DSMB) will...
newratings.com  Aug 19  Comment 
PETAH TIKVA (dpa-AFX) - ARCA biopharma Inc. (ABIO) has randomized the 100th patient in its phase 2B/3 clinical trial evaluating Gencaro as a potential treatment for atrial fibrillation. The trial, dubbed GENETIC-AF, has now reached two-thirds of...
TheStreet.com  Apr 13  Comment 
NEW YORK (TheStreet) -- Shares of ARCA biopharma  surged 22.63% to $1.03 in afternoon trading Monday after the company announced that the Food and Drug Administration had designated as a Fast Track development program the investigation of...
StreetInsider.com  Aug 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARCA+biopharma+%28ABIO%29+Reports+CTA+for+GENETIC-AF+Accepted+in+Canada/9761866.html for the full story.
Benzinga  Apr 4  Comment 
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has filed a universal shelf registration statement with the Securities and Exchange...
TheStreet.com  Mar 12  Comment 
DELAFIELD, Wis. (Stockpickr) -- Small-cap biotech stocks are all the rage on Wall Street right now. >>5 Stocks With Big Insider Buying Just take a look at shares of Oxigene , which are ripping higher today by close to 100% after the company...
StreetInsider.com  Feb 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARCA+biopharma+%28ABIO%29+Prices+%248.7M+Stock%2C+Warrants+Offering/9121317.html for the full story.
StreetInsider.com  Jan 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARCA+bio+%28ABIO%29+Reports+FDA+Acceptance+of+Gencaro+IDE+Application+%28LH%29/9036164.html for the full story.
StreetInsider.com  Dec 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/LabCorp+%28LH%29+Submits+Gencaro+IDE+to+U.S.+FDA+%28ABIO%29+/8951083.html for the full story.
StreetInsider.com  Dec 4  Comment 
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) 169.5% HIGHER; announced that it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company's new Microcyn Scar Management HydroGel. The Rx product, under...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki